PIK3CD and B-cell chronic lymphocytic leukemia: The main targets for PI3K inhibition are the four isoforms α, β, γ, and δ, collectively regulating CLL cell chemotaxis, cytoskeletal rearrangement and the interaction of leukemic cells with the tumor microenvironment.